Update from CredibleMeds

March 31, 2021 Re: Revision to the QTdrugs List We are writing to inform you that two newly marketed drugs in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the Possible Risk of TdP category. Also, if you haven’t already, we hope you will try AZCERT’s web-based decision support […]